Jg. Boyer et Jal. Earp, THE DEVELOPMENT OF AN INSTRUMENT FOR ASSESSING THE QUALITY-OF-LIFE OFPEOPLE WITH DIABETES - DIABETES-39, Medical care, 35(5), 1997, pp. 440-453
OBJECTIVES. The aim of this 2-year research project was to develop an
instrument specifically designed to assess the quality of Life of peop
le with diabetes. METHODS. The project was divided into two phases. In
the first phase, information from a detailed literature review, from
existing quality-of-life instruments, and from interviews with health
professionals and people with diabetes was used to develop an initial
instrument of 92 items considered to address important aspects of pati
ents' lives, This questionnaire was mailed to 1,000 people with diabet
es, and data from the 516 respondents were used to select the most imp
ortant and useful items. Fifty items were excluded, leaving 42 items t
hat constituted the pilot instrument. During phase 2, the pilot instru
ment was used to assess the quality of life of 427 diabetic patients w
ho completed the revised questionnaire, After analyzing this data, thr
ee additional items were dropped. The final instrument consists of 39
items and covers five dimensions of: patients' lives: Energy and Mobil
ity, Diabetes Control, Anxiety and Worry, Social Burden, and Sexual Fu
nctioning. RESULTS. The results of validity and reliability tests cond
ucted to date testify to the relevance of the 39-item questionnaire (D
iabetes-39) as a valid discriminative instrument, one which shows sign
ificant correlations with an overall quality-of-life assessment, the p
attern of diabetes severity, and comorbidity. Further, the results fro
m Diabetes-39 correlate well with the results from the established gen
eric quality-of-life instrument, the Medical Outcomes Study 36-Item Sh
ort-Form Health Survey. CONCLUSIONS. Validation of a duality-of-life i
nstrument, however, is an ongoing process. Further research is require
d to corroborate these early findings and to ensure that this is an in
strument that can capture data of greatest relevance to the diabetic p
atient and that is responsive to change in quality of life.